Chinese Bioethicists: He Jiankui’s Crime is More than Illegal Medical Practice
By Ruipeng Lei and Renzong Qiu,
The Hastings Center Bioethics Forum
| 01. 04. 2020
Professionals and the public in China first learned of the jail sentence of He Jiankui from the report of Xinhua News Agency. No information, including any interpretation, was provided by the Court. But the reported words of the sentence are so ambiguous as to leave room for different interpretations. We believe that the public has the right to know more than Xinhua News Agency reported.
The Court blames He and his accomplices for “their deliberate violence of China’s relevant regulations and medical ethics,” “the application of human embryonic gene editing technologies for which safety and efficacy have not been proven to clinical practices of assisted reproduction,” and “their action going beyond the bottom line of research/clinical ethics.” All these offences violate administrative regulations and ethical norms, but none of them are illegal under China’s civil or criminal laws. However, in listing these ethical and administrative wrongdoings in the sentence, the court may have been trying to fill the legal gap; that is extraordinary, and it should be praised.
We feel relieved that the trial in this case followed procedural law...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...